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Autoinflammatory syndromes are caused by 
dysregulation of the innate immune system, 
frequently affecting the inflammasome or other 
pathogen recognition pathways and leading to 
the overproduction of active IL-1 and IL-18 
(Masters et al., 2009). To date, there are at least 
12 known genetic causes of autoinflammatory 
disease, including familial Mediterranean fever 
(FMF), hyper-IgD syndrome, and cryopyrin- 
associated periodic syndrome. Therapeutic options 
for these diseases include nonsteroidal anti-
inflammatory drugs, corticosteroids, colchicine 
(for FMF), anti-TNF, and direct blockade of 
IL-1, which can be highly efficacious (Masters 
et al., 2009; Caso et al., 2013). IL-18 and IL-1  
are produced in many cells, including mono-
cytes and macrophages (Okamura et al., 1995; 
Ushio et al., 1996). IL-18 and IL-1 are pro-
duced as precursors and do not have a signal 
peptide to facilitate their secretion; instead, they 
are activated and released extracellularly as 
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Gain-of-function mutations that activate the innate immune system can cause systemic 
autoinflammatory diseases associated with increased IL-1 production. This cytokine is 
activated identically to IL-18 by an intracellular protein complex known as the inflamma-
some; however, IL-18 has not yet been specifically implicated in the pathogenesis of heredi-
tary autoinflammatory disorders. We have now identified an autoinflammatory disease in 
mice driven by IL-18, but not IL-1, resulting from an inactivating mutation of the actin-
depolymerizing cofactor Wdr1. This perturbation of actin polymerization leads to systemic 
autoinflammation that is reduced when IL-18 is deleted but not when IL-1 signaling is 
removed. Remarkably, inflammasome activation in mature macrophages is unaltered, but  
IL-18 production from monocytes is greatly exaggerated, and depletion of monocytes in vivo 
prevents the disease. Small-molecule inhibition of actin polymerization can remove potential 
danger signals from the system and prevents monocyte IL-18 production. Finally, we show 
that the inflammasome sensor of actin dynamics in this system requires caspase-1, apoptosis-
associated speck-like protein containing a caspase recruitment domain, and the innate im-
mune receptor pyrin. Previously, perturbation of actin polymerization by pathogens was 
shown to activate the pyrin inflammasome, so our data now extend this guard hypothesis to 
host-regulated actin-dependent processes and autoinflammatory disease.
© 2015 Kim et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial– 
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protein, pyrin, activating mutations induce ASC-dependent 
but NLRP3-independent IL-1 activation and cause severe 
autoinflammation in mice (Chae et al., 2011). Interestingly, 
pyrin interacts with ASC, microtubules, and actin filaments 
(Mansfield et al., 2001; Richards et al., 2001; Waite et al., 
2009), and it has recently been shown that modification of 
RhoGTPases by bacterial toxins can trigger the pyrin inflam-
masome, perhaps via modulation of actin dynamics (Xu et al., 
2014). This raises the fascinating prospect of a link between 
perturbations in the actin cytoskeleton and autoinflamma-
tory disease.
Wdr1 is required for disassembly of actin filaments in con-
junction with the actin-depolymerizing factor/cofilin family 
of proteins. Mice homozygous for a hypomorphic allele of 
Wdr1 (Wdr1rd/rd) exhibit spontaneous autoinflammatory dis-
ease and thrombocytopenia (Kile et al., 2007). Both defects 
have been suggested to result from a disruption in actin dy-
namics. Thrombocytopenia results from defects in megakary-
ocytes, a cell type that is entirely dependent on a functional 
cytoskeleton to shed platelets (Patel et al., 2005). Wdr1 mutant 
mice also exhibit neutrophilia; however, the critical inflam-
matory mediators and cell types important for the development 
mature proteins after cleavage by caspase-1 (Li et al., 1995; 
Ghayur et al., 1997; Gu et al., 1997). Despite these similarities, 
there is no known hereditary autoinflammatory disease where 
the pathology is caused exclusively by IL-18.
The inflammasome is an intracellular molecular platform 
that forms in response to pathogen- or danger-associated mo-
lecular patterns (DAMPs), leading to recruitment and activa-
tion of caspase-1 (Martinon et al., 2002; Schroder and Tschopp, 
2010). A growing number of inflammasomes have been re-
ported, each nucleated by a different innate immune receptor, 
such as NLRP1 (Martinon et al., 2000; Boyden and Dietrich, 
2006), NLRP3 (Agostini et al., 2004), NLRC4 (Franchi et al., 
2006), pyrin (Chae et al., 2011), and AIM2 (Hornung et al., 2009). 
Apoptosis-associated speck-like protein containing a caspase 
recruitment domain (ASC) is a key adaptor used by most of 
these innate immune receptors to interact with and recruit 
caspase-1 (Srinivasula et al., 2002). Activating mutations in 
NLRP3 result in increased IL-1 and IL-18 production, which 
can be prevented in mice by deleting caspase-1 or ASC. Fur-
thermore, deleting either the IL-18R or the IL-1R can both 
independently protect mice from this NLRP3-mediated au-
toinflammatory disease (Brydges et al., 2013). For the FMF 
Figure 1. Autoinflammatory disease in Wdr1rd/rd mice is IL-1 independent, but IL-18 dependent. (a and b) Serum cytokines/chemokines from wild-type 
(Wdr1+/+) and Wdr1rd/rd mice were analyzed by Bioplex (a) or for IL-1 and IL-18 by ELISA (b). n = 5–6. *, P < 0.05; **, P < 0.01; ***, P < 0.001 by unpaired t test, 
corrected for multiple comparisons. (c) Incidence of inflammation in tail or ears for Wdr1rd/rd, Wdr1rd/rdIL-1R/, or Wdr1rd/rdIL-18/ mice. ****, P < 0.0001 by  
Gehan-Breslow-Wilcoxon test. (d) Incidence of inflammation after reconstitution of lethally irradiated mice with BM of the indicated genotypes (donor BM→
irradiated host). ****, P < 0.0001 by Gehan-Breslow-Wilcoxon test. (e) Serum IL-18 from the mice shown in panel d was analyzed by ELISA. n = 4 or 6. Error bars 
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(unpublished data). This result suggests that neutrophilia and 
cytokines that promote neutrophilia (G-CSF, Eotaxin, and 
MCP-1) are not important for initiation of autoinflamma-
tion in Wdr1rd/rd mice.
The cutaneous inflammatory pathology of Wdr1rd/rd mice 
displayed features reminiscent of TNF- and IL-1–dependent 
diseases in humans. We therefore generated TNFR-deficient 
Wdr1rd/rd mice (Wdr1rd/rdTNFR/), and although the neutro-
phil count was reduced, the incidence of autoinflammatory 
disease remained unchanged (unpublished data). We also 
generated IL-1R–deficient Wdr1rd/rd mice (Wdr1rd/rdIL-1R/), 
and again, the pathological manifestations and onset of inflam-
matory disease were not altered (Fig. 1 c). Finally, we tested 
the influence of IL-18, which is elevated in the serum of 
Wdr1rd/rd mice, has significant effects on neutrophil function, 
and is associated with inflammatory pathology of the skin (Leung 
et al., 2001; Wittmann et al., 2009). Unlike the previous ge-
netic crosses, Wdr1rd/rdIL-18/ mice display a delayed onset of 
autoinflammatory disease (Fig. 1 c). These data show that the au-
toinflammatory disease in Wdr1rd/rd mice is regulated by IL-18. 
This is the first known example of a genetic autoinflammatory 
disease that is mediated by IL-18 but not IL-1.
IL-18 from the hematopoietic compartment  
contributes to disease in Wdr1rd/rd mice
We previously reported that the autoinflammatory disease in 
Wdr1rd/rd mice is BM intrinsic (Kile et al., 2007). To establish 
whether the pathogenic IL-18 observed in these animals de-
rives from hematopoietic cells, we generated BM chimeras 
by transplanting unfractionated BM cells into lethally irradi-
ated recipients. Consistent with our previous study (Kile 
et al., 2007), transfer of Wdr1rd/rd BM into wild-type recipients 
triggered autoinflammatory disease a median of 22 d after 
of inflammation in this genetic condition are unclear (Kile 
et al., 2007). Intriguingly, Wdr1 was found to be secreted after 
caspase-1 activation (Keller et al., 2008).
We examined the role of key inflammatory mediators 
that drive autoinflammation in Wdr1rd/rd mice and demon-
strated that this disease is IL-18 dependent, but IL-1 indepen-
dent. As expected, this IL-18 is produced by the inflammasome; 
however, it is not produced from neutrophils or macro-
phages, but instead only from monocytes. Finally, we found 
that the autoinflammatory disease was mediated by pyrin, 
providing evidence that this innate immune receptor recog-
nizes alterations in the actin polymerization pathway.
RESULTS
Autoinflammatory disease in Wdr1rd/rd mice  
is IL-1 independent, but IL-18 dependent
To identify the drivers of autoinflammation in Wdr1rd/rd mice, 
we measured serum cytokines and chemokines by Bio-Plex and 
ELISA (Fig. 1, a and b). IL-10, IL-18, G-CSF, Eotaxin, and 
MCP-1/CCL2 were found to be significantly elevated in serum 
from Wdr1rd/rd mice relative to that of wild-type littermates.
Given the increased neutrophil counts in BM, peripheral 
blood, and inflammatory lesions, we hypothesized that neu-
trophils are the principal cell types for initiating inflammation 
and are related to the elevated levels of serum Eotaxin, MCP-1, 
and G-CSF. In particular, G-CSF promotes the proliferation, 
differentiation, function, and survival of neutrophil precursors 
and mature neutrophils (Metcalf, 1985). We therefore gener-
ated G-CSF–deficient Wdr1rd/rd mice (Wdr1rd/rdG-CSF/) 
to investigate the role of neutrophils in the development of 
autoinflammation. Despite an 80% reduction in circulating 
neutrophils for Wdr1rd/rdG-CSF/ mice, autoinflammation 
developed at a similar rate and severity as in Wdr1rd/rd mice 
Figure 2. LPS-induced IL-18 secretion from 
Wdr1rd/rd monocytes, not macrophages. (a and b) 
BM from WT, Wdr1rd/rd, or IL-18/ mice was cultured 
in L929 cell-conditioned medium for 1–7 d. 105 cells 
from day 1–7 cultures were incubated with 1 µg/ml 
LPS. 48 h after stimulation, culture supernatants 
were harvested and assayed by ELISA for IL-18  
(a) and TNF (b). Error bars represent SEM of two tech-
nical replicates of two biological duplicates. (c and d) 
BM from WT, Wdr1rd/rd, or caspase-1/ mice was 
cultured in L929 cell-conditioned medium for 4 d. 
(c) Propidium iodide negative (PI-ve) and CD11bhi or 
CD11bint/low populations indicated by blue boxes were 
sorted by flow cytometry. FSC-A, forward scatter A. 
(d) 5 × 104 cells were treated with 1 µg/ml LPS for  
48 h. Secreted IL-18 was measured as in panel a.  
Error bars represent SEM of three technical replicates 
of two biological duplicates. ****, P < 0.0001 by  









f Adelaide Library user on 16 M
arch 2020
930 Pyrin drives IL-18–specific autoinflammation | Kim et al.
ex vivo. We measured LPS-induced IL-18 secretion from 
wild-type and Wdr1rd/rd day 7 BMDMs but, surprisingly, 
found no difference (Fig. 2 a). We also tested BM-derived 
DCs (cultured in GM-CSF) but found no difference in IL-18 
secretion in response to LPS. We also generated Wdr1rd/rdCD11c-
DTR-GFP BM chimeric mice, in which DCs were depleted 
by injection of diphtheria toxin (DT), that were not protected 
from disease (unpublished data).
It has been shown that IL-1 and IL-18 can be secreted 
by human monocytic THP-1 cells or inflammatory disease-
associated monocytes in response to LPS (Chae et al., 2003; 
Seshadri et al., 2007; Netea et al., 2009). F4/80+ CD11bint 
CD115(M-CSFR)+ monocytes can be found during culture 
of BM with M-CSF ex vivo, before the cells terminally dif-
ferentiate into macrophages. To examine IL-18 secretion from 
monocytes, BM was cultured in M-CSF for between 1 and 7 d, 
and cells were stimulated with LPS. IL-18 production was in-
creased in response to LPS from Wdr1 mutant BM cells when 
cultured with M-CSF, peaking between 3 and 5 d of culture 
(Fig. 2 a). In contrast, TNF secretion was not elevated between 
wild-type and Wdr1 mutant cells at all time points (Fig. 2 b). 
This result led us to further analyze the cell populations in 
reconstitution (Fig. 1 d). This was not significantly delayed 
when Wdr1 mutant BM was transplanted into an IL-18– 
deficient host (Wdr1rd/rd→IL-18/). In contrast, wild-type 
mice reconstituted with Wdr1 mutant BM lacking IL-18 
(Wdr1rd/rdIL-18/→WT) developed disease with median 
onset at 46 d (Fig. 1 d). Interestingly, genetic deletion of IL-18 
from either the hematopoietic or nonhematopoietic com-
partment led to reduced serum IL-18 levels when compared 
with wild-type recipients of Wdr1 mutant BM (Wdr1rd/rd→
WT; Fig. 1 e). Collectively, these data indicate that patho-
genic IL-18 is derived from the hematopoietic compartment 
of Wdr1rd/rd mice and that this is likely to act locally because 
decreased circulating IL-18 in IL-18/ recipients did not 
protect against Wdr1rd/rd-mediated disease.
Wdr1rd/rd M-CSF–derived cells secrete  
increased IL-18 in response to LPS
In addition to the massive infiltration of neutrophils, F4/80+ 
macrophages were found in the inflammatory lesions of the 
Wdr1rd/rd ears (Kile et al., 2007). To study inflammasome func-
tion in macrophages, we derived macrophages in M-CSF for 
7 d—the standard technique for generation of macrophages 
Figure 3. Increased IL-18 production from 
Wdr1rd/rd CD11bintCD115+ monocytes. (a) BM  
from WT or Wdr1rd/rd mice was cultured in L929  
cell-conditioned medium for 4 d. Propidium iodide  
negative (PI-ve) and CD11bint/low populations were gated 
(blue box; left). FSC-A, forward scatter A. Based on 
CD115(M-CSFR) and Gr1 immunostaining, four subsets 
of CD11bint/low populations were sorted by flow cytom-
etry (blue boxes; right). (b and c) 5 × 104 cells from 
each sorted population were incubated with 1 µg/ml 
LPS. 48 h after stimulation, culture supernatants were 
harvested and assayed by ELISA for IL-18 (b) and TNF 
(c). (d) Sorted populations were cytocentrifuged and 
examined by microscopy after May-Grünwald Giemsa 
stain. Bar, 10 µm. All data are representative of two 
independent experiments; error bars represent SEM of 
two technical replicates of two biological duplicates.  
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cells was consistent with monocytes and not mature macro-
phages (Fig. 3 d). The Wdr1 mutant monocytes were not mor-
phologically distinct from wild type; however, Wdr1 mutant 
neutrophils (CD115Gr1+) displayed prominent nuclear her-
niation (Fig. 3 d).
Clodronate liposome depletion of circulating monocytes 
prevents Wdr1rd/rd autoinflammatory disease
To establish the role of monocytes in disease pathogenesis 
in vivo, we used clodronate liposomes (van Rooijen and van 
Nieuwmegen, 1984). Clodronate or PBS liposomes were re-
peatedly injected intravenously twice per week starting 2 wk 
after mice were reconstituted with Wdr1rd/rd BM. Caspase-1–
deficient recipients were used to reduce IL-18 production 
from nonhematopoietic cells. The PBS liposome control co-
hort developed inflammation 3–4 wk after BM transplanta-
tion, whereas the group that received clodronate liposomes 
was protected from inflammation until the termination of 
liposome injection 6 wk after BM reconstitution (Fig. 4 a). 
Unexpectedly, we found that serum IL-18 levels are increased 
upon injection of clodronate liposomes, even in mice recon-
stituted with wild-type BM (unpublished data). The profound 
effect of clodronate liposomes indicated that the cells de-
pleted by clodronate were critical to initiate disease (Fig. 4 b). 
Flow cytometric analysis of peripheral blood demonstrated 
that >99% of both CD115+Gr1 resident monocytes and 
CD115+Gr1+ inflammatory monocytes were depleted by clo-
dronate administration, whereas CD115Gr1hi neutrophils were 
not affected (Fig. 4, c and d). As we have previously excluded 
a dominant role for mature macrophages, DCs, neutrophils, 
and lymphocytes in IL-18 production and inflammatory disease, 
day 3–5 BMDMs versus day 7 BMDMs. In day 7 BMDMs, 
>98% of cells displayed high and homogenous CD11b ex-
pression (CD11bhi), whereas in day 3–5 BMDMs, 40% 
(day 3) and 15% (day 5) of cells showed intermediate CD11b 
expression (CD11bint) and were distinct from CD11bhi cells 
(Fig. 2 c). To define the cell populations associated with IL-18 
secretion in day 3–5 BMDMs, CD11bhi and CD11bint from 
day 4 BMDMs were sorted by flow cytometry and cultured 
with LPS for 48 h to measure IL-18 secretion by ELISA. 
In populations of day 4 BMDMs, mutant CD11bint cells se-
creted 2.5-fold more IL-18 than equivalent wild-type cells, 
whereas IL-18 secretion from CD11bhi cells was similar be-
tween wild-type and Wdr1 mutant day 4 BMDMs (Fig. 2 d). 
Therefore, defects in Wdr1 function are driving IL-18 produc-
tion in F4/80+CD11bintCD115+ monocytes but not F4/80+ 
CD11bhiCD115+ macrophages.
Increased IL-18 production from Wdr1  
mutant F4/80+CD11bintCD115+ monocytes
To delineate specific populations in day 3–5 BMDMs with 
increased IL-18 production, four distinct populations of 
CD11bint/low cells were sorted: CD115+Gr1 (resident mono-
cytes), CD115+Gr1+ (inflammatory monocytes), CD115Gr1+ 
(neutrophils), and CD115Gr1 cells (Fig. 3 a). An IL-18 ELISA 
from culture supernatant revealed that the two CD11bint/low 
CD115+ populations were the principal cell types secreting 
IL-18 in day 4 Wdr1 mutant BMDMs; immunophenotypi-
cally, these were resident (CD115+Gr1) and inflammatory 
(CD115+Gr1+) monocytes (Fig. 3 b). In contrast, TNF secre-
tion in response to LPS was normal in Wdr1 mutant cells 
(Fig. 3 c). The cellular morphology of CD11bint/lowCD115+ 
Figure 4. Clodronate liposome depletion 
of circulating monocytes prevents Wdr1rd/rd 
autoinflammatory disease. Lethally irradi-
ated chimeric mice containing Wdr1rd/rd BM 
were injected intravenously with clodronate 
liposomes (Clo-lipo) or PBS liposomes (PBS-
lipo) twice per week starting from 2 wk after 
BM reconstitution. (a) Incidence of inflamma-
tion from chimeric mice after BM reconstitu-
tion. (b) After eight injections of liposomes, 
two representative mice from each group 
were photographed, and an ear from each 
mouse is highlighted. (c and d) 24 h after the 
fourth injection of liposomes, peripheral blood 
leukocytes were analyzed by flow cytometry 
as indicated by pink boxes (c) and quantified 
as CD115+Gr1 resident monocytes, 
CD115+Gr1+ inflammatory monocytes, and 
CD115Gr1hi neutrophils (d). Error bars repre-
sent means ± SEM (n = 5). **, P < 0.01 by 
Gehan-Breslow-Wilcoxon test; ***, P < 0.001 
by unpaired t test. All data are representative 
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monocytes in the absence of LPS. In the presence of 
latrunculin-b or colchicine, LPS-induced caspase-1 activation 
and IL-18 production were reduced, suggesting a direct role 
of a dysfunctional actin cytoskeleton during inflammasome ac-
tivation in Wdr1 mutant cells (Fig. 6, a–c). Cleavage and activa-
tion of caspase-1 by nigericin was included as a positive control 
and was found to be normal in Wdr1 mutant monocytes.
Finally, we used inhibitors of the Rho/Rho-associated 
protein kinase pathway to promote actin depolymerization, spe-
cifically the Arp2/3 inhibitor CK-666 and the Rho-associated 
protein kinase inhibitor Y27632. IL-18 production by Wdr1xn/rd 
monocytes was significantly decreased when these inhibitors 
were present (Fig. 6 d). Phalloidin staining of actin confirmed 
that all inhibitors worked as expected, to decrease filamentous 
actin (Fig. 6 e). This provides further evidence that polymer-
ized actin, or a byproduct thereof, activates the inflamma-
some and triggers IL-18 production. In summary, these 
small-molecule inhibitors show that the DAMP that activates 
the inflammasome because of loss of Wdr1 is in the actin poly-
merization pathway, is specific to monocytes, and causes IL-
18–dependent pathology in vivo.
Wdr1rd/rd autoinflammatory disease  
is controlled by the pyrin inflammasome
To determine whether pathogenic IL-18 in the Wdr1 mutant 
mice is mediated by caspase-1, we generated caspase-1– 
deficient Wdr1rd/rd mice. Relative to their Wdr1rd/rd counter-
parts, serum IL-18 levels were profoundly reduced in Wdr1rd/rd 
Casp1/ animals (Fig. 7 a). Consistent with the central role 
of IL-18 in this disease, the onset of inflammation was sig-
nificantly delayed in Wdr1rd/rd Casp1/ mice (Fig. 7 b). It 
has been noted that caspase-1–deficient mice are also defi-
cient for caspase-11 (Kayagaki et al., 2011) and that caspase-
11 can interact with Wdr1 (Li et al., 2007). Formally testing 
Casp11/-deficient mice, however, revealed no protection 
from disease (Fig. 7 b). These data indicated that caspase-1 
plays a key role in the development of autoinflammatory disease 
and prompted us to investigate the upstream innate immune 
these data suggest that local production of IL-18 by infiltrat-
ing monocytes is a key initiating event in disease pathology in 
Wdr1rd/rd mice.
Polymerized actin triggers ASC specks, caspase-1 activation, 
and IL-18 secretion in Wdr1 mutant monocytes
To study this system in more detail, we were interested to ex-
amine monocytes with a more severe defect in Wdr1 func-
tion. It was previously shown that the rd allele of Wdr1 is 
hypomorphic and not a complete loss of function, whereas 
Wdr1 deficiency caused by a gene-trap allele (Wdr1xn/xn) 
causes embryonic lethality because of developmental ab-
normalities (Kile et al., 2007). The compound heterozygote 
(Wdr1xn/rd) exhibits an intermediate phenotype, and mice die 
at birth from an unknown etiology (unpublished data). In 
agreement with a more severe loss of Wdr1 function, Wdr1xn/rd 
embryonic day 14.5 (E14.5) fetal liver–derived monocytes 
(FLDMs) secreted very high levels of IL-18 in response 
to LPS compared with healthy Wdr1+/rd controls (Fig. 5 a). 
To establish whether this is dependent on the activity of 
caspase-1, we used the caspase-1 inhibitor VX-765. LPS-treated 
Wdr1xn/rd day 3 FLDMs showed reduced IL-18 production 
in the presence of VX-765 (Fig. 5 b). Furthermore, con-
focal analysis of the inflammasome adaptor ASC revealed 
spontaneous specks that were increased by treatment with 
LPS (Fig. 5 c).
Next, we used latrunculin-b and colchicine to determine 
the role of the actin cytoskeleton in caspase-1 activation and 
IL-18 secretion. Latrunculins are marine toxins that disrupt 
microfilament organization in cultured cells and can disrupt 
actin polymerization (Spector et al., 1983, 1989). Colchicine 
is another cytoskeletal drug that functions to inhibit micro-
tubule polymerization by binding to tubulin, and it can pre-
vent inflammasome activation in gout and FMF (Özkaya 
and Yalçinkaya, 2003). We measured the effects of latrun-
culin-b and colchicine on LPS-induced caspase-1 activation 
and IL-18 secretion in both Wdr1rd/rd and Wdr1xn/rd mono-
cytes by Western blotting and ELISA (Fig. 6, a–c). Caspase-1 
activation was not detected in either wild-type or mutant 
Figure 5. Caspase-1 and ASC activation in Wdr1 mutant monocytes. E14.5 fetal livers from Wdr1+/rd or Wdr1xn/rd embryos were cultured in L929 
cell-conditioned medium for 3 d. (a and b) 105 FLDMs from day 3 cultures were incubated with 1 µg/ml LPS (a) or treated with LPS ± VX-765 (b). 48 h 
after stimulation, culture supernatants were harvested and assayed by ELISA for IL-18. (c) 24 h after stimulation, cells were fixed and permeabilized, with 
intracellular ASC specks stained and then imaged by confocal microscopy. All data are representative of two to four independent experiments; error bars 
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NLRP1, do not (Masters et al., 2012). Deletion of NLRP1 
did not protect Wdr1 mutant mice, whereas the deletion of 
ASC did delay the onset of inflammatory disease (Fig. 7 c), 
showing that innate immune receptor activation requires the 
downstream adaptor protein ASC. We crossed Wdr1rd/rd mice 
receptor that may detect perturbed actin polymerization in 
Wdr1rd/rd mice.
Several innate immune receptors engage with caspase-1 
to form multiprotein inflammasome complexes. Many of these 
require the adaptor molecule ASC; however, others, such as 
Figure 6. Inhibition of actin polymerization prevents caspase-1 activation and IL-18 secretion from Wdr1 mutant monocytes. (a) West-
ern blot analysis of caspase-1 in the supernatant from wild-type (WT), caspase-1/ (Casp1/), and Wdr1rd/rd day 4 BMDM culture. A long exposure 
(long exp.) is also presented for the cleaved caspase-1 (p20) band. Cells were left untreated, stimulated with 1 µg/ml LPS, or incubated with 10 µM 
nigericin after LPS priming. Additionally, wild-type and Wdr1rd/rd cells were pretreated with 1 µM latrunculin-b or 1 µM colchicine for 30 min before 
LPS stimulation. MW, molecular weight. (b–d) Day 4 FLDMs from Wdr1+/rd or Wdr1xn/rd were left untreated or treated with LPS plus an increasing dose 
of latrunculin-b (Lat-b; b) or colchicine (Col; c) for 16 h, or with LPS in the presence of 100 µM CK-666 or 50 µM Y27632 for 48 h (d). Secreted IL-18 
in the culture supernatants was measured by ELISA. (e) Day 3 wild-type or Wdr1rd/rd BMDMs were stimulated with LPS for 24 h in the presence of the 
inhibitors used previously and then were fixed and stained with phalloidin to detect filamentous actin. Green, phalloidin-FITC; blue, nuclei-DAPI. 
Bar, 50 µm. All data are representative of two to four independent experiments; error bars represent means ± SEM (n = 3–4). *, P < 0.05; ***, P < 0.001; 
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serum IL-18 was no longer elevated (Fig. 7 e). Although the 
Wdr1rd/rdPyrin/ cross was performed in a separate facility 
(National Institutes of Health, Bethesda, MD) than the other 
inflammasomes (The Walter and Eliza Hall Institute of Medi-
cal Research, Parkville, Australia), a role for different micro-
biota is unlikely because this disease proceeds in a gnotobiotic 
facility (Fig. 7 f).
Recently, a trigger for the pyrin inflammasome has been 
proposed, downstream of RhoGTPase modification by bac-
terial effectors such as Clostridium difficile Toxin B (TcdB; Xu 
et al., 2014). We therefore tested this recombinant toxin on 
Wdr1rd/rd monocytes and observed a significant increase in 
IL-18 production compared with wild type (Fig. 8 a). IL-18 
production after stimulation of the NLRP3 inflammasome 
with nigericin was unaltered (Fig. 8 a). Notably, IL-1 pro-
duction was negligible unless first primed with LPS (Fig. 8 b). 
This suggests that the IL-18 specificity in this disease may 
to different ASC-dependent, inflammasome-deficient mice. 
NLRP3 was an excellent candidate, as it can be activated in 
response to different danger signals; however, a deficiency of 
NLRP3 afforded no protection from disease (Fig. 7 d). Given 
the nuclear herniation observed in Wdr1rd/rd neutrophils, it 
was possible that DNA was being sensed by the AIM2 in-
flammasome; however, a deficiency in AIM2 also afforded 
no protection from disease (Fig. 7 d). Recently, it has been 
shown that NLRC4 is activated in response to changes in 
actin polymerization during Salmonella enterica Typhimurium 
infection (Man et al., 2014), but NLRC4 deficiency played 
no obvious role in this model of sterile inflammation (Fig. 7 d). 
Finally, we tested the pyrin (Mefv) inflammasome, which is 
reported to directly interact with actin (Mansfield et al., 2001; 
Richards et al., 2001; Waite et al., 2009). We found that 
Wdr1rd/rdPyrin/ mice were protected from disease com-
pared with Wdr1rd/rd littermate controls (Fig. 7 d) and that 
Figure 7. Pyrin-dependent IL-18 secretion and inflammation in Wdr1 mutant mice. (a) Serum IL-18 from WT, Wdr1rd/rd, and Wdr1rd/rdCasp1/ 
mice. n = 5–13. *, P < 0.05; **, P < 0.01 by unpaired t test. (b) Incidence of inflammation from Wdr1rd/rd, Wdr1rd/rdCasp1/, and Wdr1rd/rdCasp11/ mice. 
****, P < 0.0001 by Gehan-Breslow-Wilcoxon test. (c) Incidence of inflammation from Wdr1rd/rd, Wdr1rd/rdNlrp1/, Wdr1rd/rdNlrp3/, and Wdr1rd/rdAsc/ 
mice. ***, P < 0.001 by Gehan-Breslow-Wilcoxon test. (d) Incidence of inflammation from Wdr1rd/rd, Wdr1rd/rdNlrc4/, Wdr1rd/rdAim2/, and Wdr1rd/rdPyrin/ 
mice. ****, P < 0.0001 by Gehan-Breslow-Wilcoxon test. (e) Serum IL-18 from WT, Pyrin/, Wdr1rd/rd, and Wdr1rd/rdPyrin/ mice. (f) Wdr1rd/rd mice were 
rederived in a gnotobiotic facility to establish any potential role for commensal microbes in the inflammatory pathology caused by a loss of Wdr. This is 
compared with conventionally housed Wdr1rd/rd and Wdr1rd/rdIL-18/ mice. ***, P < 0.001; ****, P < 0.0001 by Gehan-Breslow-Wilcoxon test. Except for 
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are so dynamic and tightly regulated at a subcellular level, 
these data are not in conflict with ours but do emphasize the 
complexity by which actin and pyrin are regulated. It is 
tempting to speculate that the trigger is some modified form 
of actin given that pyrin binds to, and colocalizes with, po-
lymerizing actin (Mansfield et al., 2001; Richards et al., 2001; 
Waite et al., 2009). However, further work is required to in-
vestigate this interaction.
Our results highlight that the pyrin inflammasome is a 
potent platform for IL-18 production. This has direct impli-
cations for diseases where pyrin is activated, such as in FMF, 
or as a result of infections such as C. difficile or Burkholderia 
cenocepacia, where effectors target RhoGTPases. Indeed, it is 
known that IL-18 is elevated in FMF (Haznedaroglu et al., 
2005), and although therapy blocking IL-1 was found to be 
beneficial, the effect of blocking IL-18 may be more robust 
and is worth exploring in preclinical models. However, for 
infection with C. difficile or B. cenocepacia, IL-18 may actually 
be beneficial in restoring normal homeostasis (Ceballos- 
Olvera et al., 2011; Elinav et al., 2011). IL-18 may also be as-
sociated with inflammatory diseases caused by other bacterial 
effectors that target RhoGTPases, which are found in a broad 
range of mucosal pathogens (Müller et al., 2010), or microbes 
that hijack host actin cytoskeletal machinery, such as Listeria 
or Shigella (Gouin et al., 2005).
In summary, our data show that innate immune surveil-
lance of actin dynamics is not confined to settings of infection 
but also alerts the host cell to changes in actin depolymeriza-
tion and contributes to autoinflammatory disease that is de-
pendent on IL-18, not IL-1.
MATERIALS AND METHODS
Mice. IL-18/ (Takeda et al., 1998), IL-1R/ (Thomas et al., 2004), 
IFN/ (Dalton et al., 1993), TNFR/ (Pfeffer et al., 1993), G-CSF/ 
(Lieschke et al., 1994), Nlrp1/ (Masters et al., 2012), Nlrp3/ (Martinon 
et al., 2006), Asc/ (Mariathasan et al., 2004), Casp-1/ (Li et al., 1995), 
Aim2/ (Hornung et al., 2009), Pyrin/ (Chae et al., 2003), CD11c-DTR 
(Jung et al., 2002), and Nlrc4/ (Franchi et al., 2006) mouse strains were 
crossed with Wdr1rd/rd (Kile et al., 2007) mice. All mice were backcrossed 
at least 10 generations to C57BL/6, and littermates were used as controls. 
Lesions were assessed by independent observers three times per week and 
defined as redness, swelling, lumps, scabs, or lesions and were marked for the 
first day when inflammation appeared on the ears or tail.
All animal experiments complied with the regulatory standards of, and 
were approved by, The Walter and Eliza Hall Institute Animal Ethics Com-
mittee or National Institutes of Health Office of Laboratory Animal Welfare.
arise because it is a sterile inflammatory condition without 
significant IL-1 priming in monocytes. In total, these data 
indicate that the pyrin inflammasome, including ASC and 
caspase-1, alerts the host cell to perturbations in the process 
of actin depolymerization.
DISCUSSION
Pyrin was the first protein implicated in autoinflammatory 
disease due to mutations that activate the innate immune sys-
tem in FMF (The International FMF Consortium, 1997). 
Subsequent work showed that this protein formed an inflam-
masome complex for the activation of IL-1 and IL-18 and 
that it is also an actin-binding protein (Mansfield et al., 2001; 
Richards et al., 2001; Waite et al., 2009). We now show that 
a lack of actin depolymerization triggers the pyrin inflamma-
some in vivo, using a mouse model of autoinflammatory dis-
ease. However, deletion of pyrin inflammasome components 
did not totally rescue the disease, suggesting that other in-
flammatory processes are also contributing to the phenotype. 
Crosses to mice lacking Clec9a, or other innate immune re-
ceptors that may recognize perturbations in actin polymeriza-
tion, are currently under way.
Unlike all known hereditary autoinflammatory disorders, 
the disease described here is ameliorated by genetic deletion 
of IL-18, whereas genetic removal of IL-1 has no discern-
ible effect on disease initiation. Given that these two proin-
flammatory cytokines are generated by the same enzymatic 
reaction, this observation is quite unique and raises the ques-
tion about how this selectivity may arise. Our data suggest 
that this is because of cell type, with a prominent role for the 
monocyte in disease development. Baseline levels of IL-18 in 
monocytes are higher than IL-1, which requires priming 
through a TLR for maximal induction, as shown in Fig. 8. 
The pattern of expression of pyrin may also explain the im-
portance of the monocyte, where it is elevated compared 
with macrophages, or other hematopoietic cells, with the ex-
ception of some DCs (Seshadri et al., 2007). Additionally, 
monocytes may generate increased amounts of incompletely 
depolymerized, severed actin filaments and/or accumulate 
inflammatory DAMPs downstream of these events. This also 
highlights that the biochemical entity engaging pyrin has yet 
to be properly defined. In contrast to our findings, Xu et al. 
(2014) document that pyrin is triggered downstream of 
bacterial effectors that target RhoGTPases, which were pre-
dicted to decrease actin polymerization. As these processes 
Figure 8. Enhanced IL-18 production from 
Wdr1 mutant monocytes in response to TcdB. 
Wild-type and Wdr1rd/rd day 3 BMDMs were left un-
treated or stimulated with 20 ng/ml TcdB for 3 h or 
10 µM nigericin (Nig) for 1 h with or without 1 µg/ml 
LPS. (a and b) Secreted IL-18 (a) or secreted IL-1  
(b) in the culture supernatants was measured by ELISA. 
All data are representative of two independent ex-
periments; error bars represent means ± SEM (n = 3). 
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with 1 µg/ml LPS for 4 h, washed with DMEM, and incubated with or 
without 10 µM nigericin (Enzo Life Sciences) in DMEM for 44 h. Addition-
ally, wild-type and Wdr1rd/rd cells were pretreated with 1 µM latrunculin-b 
(Enzo Life Sciences) or 1 µM colchicine (Sigma-Aldrich) for 30 min before 
LPS priming for 4 h, washed with DMEM, and incubated for 44 h with or 
without latrunculin-b or colchicine. Culture supernatants were then col-
lected and enriched by methanol chloroform precipitation (Masters et al., 
2010). Precipitates were boiled for 5 min with SDS sample buffer, resolved 
by SDS/PAGE, and transferred to polyvinylidene fluoride membranes. After 
blocking in PBS with 0.1% Tween 20 and 5% skim milk for 1 h, membranes 
were then probed overnight at 4°C with anti–caspase-1 (p20; AdipoGen).
Immunofluorescence for endogenous ASC specks or filamentous 
actin. Day 3 BMDMs were seeded onto RetroNectin-coated chamber 
slides (Takara Bio Inc.) and stimulated as described in figure legends. Cells 
were then fixed with 4% paraformaldehyde in PBS for 30 min and washed 
twice in PBS before blocking and permeabilization in blocking buffer (PBS, 
10% FCS, and 0.5% Triton X-100) for 60 min. Staining was then performed 
with primary antibodies ASC (1:500 N-15; Santa Cruz Biotechnology, Inc.) 
or phalloidin-FITC (1:400; Sigma-Aldrich) in blocking buffer overnight at 
4°C. Cells were washed three times with blocking buffer, and secondary an-
tibody staining for ASC was performed with goat anti–rabbit Alexa 647 
(1:1,000; Invitrogen) in blocking buffer for 60 min at room temperature (in 
the dark). Cells were washed twice with PBS before imaging. Images were 
acquired with a confocal microscope (LSM 780; Carl Zeiss) at room tem-
perature using a 40× oil objective with Immersol 518 F (refractive index n = 
1.518; Carl Zeiss) and a 1.4 numerical aperture and were acquired with ZEN 
2012 v8.1 software (Carl Zeiss). Image channels were merged and converted 
to TIFF using FIJI software.
Statistical analysis. Data are presented as means ± SEM. Statistical signifi-
cance was determined with the Student’s t test or ANOVA using Prism soft-
ware (GraphPad Software Inc.) as described in the figure legends. Multiple 
comparisons were corrected using the Holm-Šidák method; inflammation 
incidence curves were compared by Gehan-Breslow-Wilcoxon test.
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